Funding Rounds
Artios Pharma Series C (2021, $152M)
Artios PharmaIndependent biotech company focused on developing new cancer therapies targeting DNA damage response.
Summary
Stage: Series C
Raised Amount: $152.70M
Raised Date: 2021-01-01
Stage: Series C
Raised Amount: $152.70M
Raised Date: 2021-01-01